Q1 2026 13F · SEC CIK 1637946
General Catalyst Group Management, LLC
Hedge fundFiled 2026-05-15 for Q1 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $183.6M
- Reported positions
- 12
- Top holdings a year, 3 yrs
- +14.1%
- Assets under management
- $45.5B
General Catalyst Group Management, LLC is a hedge fund that reported 12 positions worth $183.6M in its Q1 2026 13F, filed 2026-05-15. Its largest holdings were Samsara, Inc. (IOT, 34.5%), Arrivent Biopharma Inc (AVBP, 18.8%), Maze Therapeutics Inc (MAZE, 16.8%). A portfolio copying its top holdings returned 14.1% a year over the last 3 years, against 20.4% for the S&P 500.
General Catalyst Group Management, LLC holdings all 12 positions.
Weights are shares of the filer's total reported 13F value, compared with Q4 2025. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| IOTSamsara, Inc. | 34.5% | +0.0% | $63.4M |
| AVBPArrivent Biopharma Inc | 18.8% | +0.0% | $34.5M |
| MAZEMaze Therapeutics Inc | 16.8% | +0.0% | $30.9M |
| CARTMaplebear Inc. | 14.5% | +0.0% | $26.6M |
| GTLBGitLab Inc | 10.9% | +0.0% | $19.9M |
| EIKNEikon Therapeutics Inc | 1.8% | — | $3.2M |
| GUTSFractyl Health Inc | 1.2% | +0.0% | $2.2M |
| LIFEEthos Technologies, Inc | 0.5% | — | $829K |
| CPNGCoupang Inc | 0.4% | — | $692K |
| AMZNAmazon Com Inc Com | 0.3% | — | $538K |
| METAMeta Platforms Inc Class A | 0.2% | — | $376K |
| FIGFigma Inc | 0.2% | +0.0% | $314K |
What General Catalyst Group Management, LLC bought and sold in Q1 2026, against Q4 2025.
New positions
- EIKN Eikon Therapeutics Inc1.8% of 13F
- LIFE Ethos Technologies, Inc0.5% of 13F
- CPNG Coupang Inc0.4% of 13F
- AMZN Amazon Com Inc Com0.3% of 13F
- META Meta Platforms Inc Class A0.2% of 13F
Added to
No position grew by more than 5%.
Reduced
No position shrank by more than 5%.
Sold out
Nothing sold out.
Share counts compared with the Q4 2025 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- -0.9% /yr
- S&P 500 +20.1%
- 3 years
- +14.1% /yr
- S&P 500 +20.4%
- 5 years
- -3.7% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q1 2026 | $183.6M | 12 |
| Q4 2025 | $221.7M | 7 |
| Q3 2025 | $3.0B | 8 |
| Q2 2025 | $4.3B | 10 |
| Q1 2025 | $887.5M | 11 |
| Q4 2024 | $1.1B | 11 |
| Q3 2024 | $1.4B | 11 |
| Q2 2024 | $1.2B | 11 |
| Q1 2024 | $1.3B | 11 |
| Q4 2023 | $1.3B | 10 |
| Q3 2023 | $1.1B | 11 |
| Q2 2023 | $1.2B | 10 |
Questions about General Catalyst Group Management, LLC's portfolio
What stocks does General Catalyst Group Management, LLC own?
General Catalyst Group Management, LLC's latest 13F, for Q1 2026 and filed May 15, 2026, lists 12 positions worth $183.6M. The largest are Samsara, Inc. (IOT) at 34.5%, Arrivent Biopharma Inc (AVBP) at 18.8%, Maze Therapeutics Inc (MAZE) at 16.8%, Maplebear Inc. (CART) at 14.5% and GitLab Inc (GTLB) at 10.9%.
What did General Catalyst Group Management, LLC buy last quarter?
In Q1 2026, General Catalyst Group Management, LLC added a new position in Eikon Therapeutics Inc (EIKN), a new position in Ethos Technologies, Inc (LIFE), a new position in Coupang Inc (CPNG), a new position in Amazon Com Inc Com (AMZN) and a new position in Meta Platforms Inc Class A (META), compared with its Q4 2025 filing.
What did General Catalyst Group Management, LLC sell last quarter?
General Catalyst Group Management, LLC sold out of nothing and cut no large position by more than 5% in Q1 2026.
How has General Catalyst Group Management, LLC's portfolio performed?
A portfolio copying General Catalyst Group Management, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +14.1% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: -0.9% against +20.1%. Over 5 years: -3.7% a year against +11.6%.
When is General Catalyst Group Management, LLC's next 13F filing due?
13F filings are due 45 days after each quarter ends. General Catalyst Group Management, LLC's filing for the quarter ending Jun 30, 2026 was due by Aug 14, 2026; this page updates once it is processed.
How much money does General Catalyst Group Management, LLC manage?
General Catalyst Group Management, LLC reported $45.5B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $183.6M.